[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339668-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339668-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hur-controls-glutaminase-rna-metabolism","HuR Controls Glutaminase RNA Metabolism","","Glutaminase (GLS) drives cancer cell growth and tumor progression by fueling metabolic pathways, making it an important therapeutic target. This article investigates the RNA-binding protein HuR (ELAVL1) and shows it regulates GLS mRNA alternative splicing and affects isoform translation and stability in breast cancer. Higher ELAVL1 expression associates with increased glutaminase isoforms GAC and kidney-type KGA and worse patient prognosis. Silencing ELAVL1 lowers KGA, raises GAC, enhances glutamine anaplerosis into the TCA cycle, and promotes glutamine dependence, while dual GLS inhibition and ELAVL1 knockdown synergistically suppress growth and invasion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hur-controls-glutaminase-rna-metabolism/339668/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hur-controls-glutaminase-rna-metabolism/339668.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does HuR (ELAVL1) play in glutaminase regulation?","Question",{"text":63,"@type":64},"HuR regulates GLS mRNA alternative splicing and influences isoform translation and stability in breast cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ELAVL1 expression relate to glutaminase isoforms and prognosis?",{"text":68,"@type":64},"Elevated ELAVL1 correlates with high levels of the GLS isoforms GAC and kidney-type KGA, which are associated with poor patient prognosis.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens when ELAVL1 is knocked down in breast cancer cells?",{"text":72,"@type":64},"ELAVL1 knockdown reduces KGA and increases GAC levels, enhances glutamine anaplerosis into the TCA cycle, and shifts cells toward glutamine dependence.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339668,1790639254,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Article [https://doi.org/10.1038/s41467-024-49874-x](https://doi.org/10.1038/s41467-024-49874-x)  \n\n| HuR controls glutaminase RNA metabolism |  |  |\n| --- | --- | --- |\n| Received: 16 June 2020\u003Cbr>Accepted: 21 June 2024 Check for updates | Douglas Adamoski 1,2, Larissa M. dos Reis 1,2,3,\u003Cbr>Ana Carolina Paschoalini Mafra 1,2,7, Felipe Corrêa-da-Silva2,3,\u003Cbr>Pedro Manoel Mendes de Moraes-Vieira 3, Ioana Berindan-Neagoe 4, George A. Calin 5,6 & Sandra Martha Gomes Dias 1 \u003Cbr>Glutaminase (GLS) is directly related to cell growth and tumor progression, making it a target for cancer treatment. The RNA-binding protein HuR (encoded by the ELAVL1 gene) inﬂuences mRNA stability and alternative splicing. Overexpression ofELAVL1 is common in several cancers, including breast cancer. Here we show that HuR regulates GLS mRNA alternative splicing and isoform translation/stability in breast cancer. Elevated ELAVL1 expression correlates with high levels of the glutaminase isoforms C (GAC) and kidneytype (KGA), which are associated with poor patient prognosis. Knocking down ELAVL1 reduces KGA and increases GAC levels, enhances glutamine anaplerosis into the TCA cycle, and drives cells towards glutamine dependence. Furthermore, we show that combining chemical inhibition of GLS withELAVL1 silencing synergistically decreases breast cancer cell growth and invasion. These ﬁndings suggest that dual inhibition of GLS and HuR offers a therapeutic strategy for breast cancer treatment. |  |\n| Glutamine is a key nutrient for cancer cells, providing carbons for lipid, amino acid, and ATP synthesis through the TCA cycle. Moreover, glutamine metabolism provides nitrogen for nucleotide’s nitrogenous base and amino acid synthesis and participates in glutathione and NADPH production, which is relevant for maintaining redox balance1. Glutaminase converts glutamine into glutamate, which is further converted to α-ketoglutarate, a key metabolite for replenishing TCA cycle intermediates, especially in cells undergoing aerobic glycolysis (known as the Warburg effect)2. Glutaminase is a promising target for treating many tumor types. One glutaminase inhibitor, telaglenastat (CB-839)3–6, is under phase I/II clinical trials6 for multiple solid and hematopoietic tumors, including breast cancers.\u003Cbr>Glutaminase is encoded by the GLS and GLS2 genes. GLS2 forms two isoforms, liver-type glutaminase (LGA) and glutaminase B (GAB), and is conditionally pro-tumorigenic7. GLS undergoes alternative splicing to produce two transcripts: KGA and GAC. The GLS gene presents |  | 19 exons; both GAC and KGA possess exons 1-14. The insertion of exon 15 generates the GAC isoform, while the skipping of exon 15, followed by the inclusion of exons 16–19, generates KGA3,8. Both isoforms present a conserved glutaminase domain similar to that of bacterial glutaminases9, which is ﬂanked by a long N-terminal domain folded inan EF-hand-like four-helix bundle and a C-terminal domain9. KGA presents a long C-terminus with three putative ankyrin repeats, whereas GAC possesses a short unstructured C-terminus. Moreover, KGA and GAC also carry distinct 3′ and 5′ untranslated regions (UTRs)10. The GAC isoform, compared to KGA, is more highly expressed in many tumor types11,12, which may be related to the fact that GACis more catalytically active12–14.\u003Cbr>GLS is regulated transcriptionally, posttranscriptionally, and posttranslationally through various mechanisms8,15–17. C-Jun, for example, is a direct transcriptional regulator of GLS expression15. On the other hand, the oncogenic transcription factor c-Myc |\n\n1Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, Brazil. 2Graduate Program in Genetics and Molecular Biology, Institute of Biology University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil. 3Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Immunometabolism, Institute of Biology, Un","cbCaiqYOzbmd8jTF","https://ap.wps.com/l/cbCaiqYOzbmd8jTF","pdf",9394441,"English","# HuR regulates GLS mRNA processing\n## GLS and glutamine metabolism in cancer\n## Alternative splicing of GLS to KGA and GAC\n## ELAVL1/HuR links to prognosis and therapeutic synergy","[{\"question\":\"What role does HuR (ELAVL1) play in glutaminase regulation?\",\"answer\":\"HuR regulates GLS mRNA alternative splicing and influences isoform translation and stability in breast cancer cells.\"},{\"question\":\"How does ELAVL1 expression relate to glutaminase isoforms and prognosis?\",\"answer\":\"Elevated ELAVL1 correlates with high levels of the GLS isoforms GAC and kidney-type KGA, which are associated with poor patient prognosis.\"},{\"question\":\"What happens when ELAVL1 is knocked down in breast cancer cells?\",\"answer\":\"ELAVL1 knockdown reduces KGA and increases GAC levels, enhances glutamine anaplerosis into the TCA cycle, and shifts cells toward glutamine dependence.\"}]","HuR Controls Glutaminase RNA Metabolism | PDF",1790031529,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55a04a6d1cd3eaca36bbc51c5dfb8428.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a880428894e43085cd3be8a645cfc1d.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30503eb7fcca37da6e62465604f471e3.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0ddca2fffcb6660162b0800b12b0a19.webp",980,1301]